Helius Medical Technologies, Inc. Provides Update on FDA’s Review of its Request for De Novo Classification
Helius Medical Technologies Receives Medical Device License Clearance from Health Canada for PoNS Device
Juggernaut Announces Strategic Investment by Crescat Capital Funds for 28.95% Ownership - Dr. Quinton Hennigh Technical Advisor
